November 26, 2019
Alpha Tau Medical
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.
Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...
August 22, 2018
CTECH by Calcalist
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars.
Israeli oncology company Alpha Tau Medical Ltd. is in the last stages of raising an investment of several tens of millions of dollars, one person familiar with the matter to...
NIKKEI ASIAN REVIEW
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation therapy equipment in Japan in 2021, at the earliest.
The product is designed to treat patients with breast, skin and other solid cancers...
In the Media
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and IFO
November 7, 2018
First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World!
March 23, 2018
Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices
April 11, 2019